RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer. [electronic resource]
Producer: 20151208Description: 1038-47 p. digitalISSN:- 1546-170X
- Anaplastic Lymphoma Kinase
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- Dual Specificity Phosphatase 6 -- physiology
- Humans
- Lung Neoplasms -- drug therapy
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Mitogen-Activated Protein Kinases -- physiology
- Oncogene Proteins, Fusion -- analysis
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.